Any systemic treatment vs placebo
Methotrexate · people with chronic plaque psoriasis
Any systemic treatment may leads to higher methotrexate compared with placebo (low certainty).
2 findings from 1 review
- Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis 2020 · Cochrane Headline outcomes onlyRR 9.78 [7.15, 13.37]3 studies · 318 participantsLow
- Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis 2020 · Cochrane Headline outcomes onlyRR 0.43 [0.2, 0.95]3 studies · 319 participantsModerate